Lingappa, J. R., Baeten, J. M., Wald, A., Hughes, J. P., Thomas, K. K., Mujugira, A., . . . Celum, C. (2010). Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: A randomised placebo-controlled trial. The Lancet (British edition), 375(9717), 824-833. https://doi.org/10.1016/S0140-6736(09)62038-9
Citácia podle Chicago (17th ed.)Lingappa, Jairam R., et al. "Daily Aciclovir for HIV-1 Disease Progression in People Dually Infected with HIV-1 and Herpes Simplex Virus Type 2: A Randomised Placebo-controlled Trial." The Lancet (British Edition) 375, no. 9717 (2010): 824-833. https://doi.org/10.1016/S0140-6736(09)62038-9.
Citácia podľa MLA (8th ed.)Lingappa, Jairam R., et al. "Daily Aciclovir for HIV-1 Disease Progression in People Dually Infected with HIV-1 and Herpes Simplex Virus Type 2: A Randomised Placebo-controlled Trial." The Lancet (British Edition), vol. 375, no. 9717, 2010, pp. 824-833, https://doi.org/10.1016/S0140-6736(09)62038-9.